Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Active targeting of bilosomes with lactoferrin ligand for nose-to-brain applications | Synapse
March 3, 2026
Active targeting of bilosomes with lactoferrin ligand for nose-to-brain applications
CF
Camille Favre
Centre National de la Recherche Scientifique
JA
Justine Aussourd
FM
Fabien Montury
See all
Key Points
Enhanced drug delivery to the brain using active targeting techniques with lactoferrin.
Lactoferrin specifically binds to receptors that facilitate brain uptake of bilosomes.
The study highlights the potential for improved treatments by utilizing nose-to-brain pathways.
Further validation in diverse models is essential to establish clinical relevance.
Abstract
International audience
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Favre et al. (Tue,) studied this question.
synapsesocial.com/papers/69a76222c6e9836116a30387
Mark Helpful
Like
Save
Bookmark
Relay
Share